ASSOBRAFIR Ciência
https://assobrafirciencia.org/article/doi/10.47066/2177-9333.AC.2022.0048
ASSOBRAFIR Ciência
Artigo de Revisão

Dispneia: revisão integrativa sobre o conceito da falta de ar

Helena Paes Zamparette, Renata Maba Gonçalves Wamosy, Camila Isabel Santos Schivinski

Downloads: 3
Views: 159

Resumo

Introdução: Dispneia é um sintoma angustiante e que muitas vezes limita as atividades de vida diária (AVD’s). É um sintoma que pode ser expressado de diferentes formas como: “falta de ar” e “angústia no peito”. Objetivo: Identificar definições e conceitos sobre a dispneia ou falta de ar presentes na literatura científica. Métodos: conduziu-se uma revisão integrativa por meio de pesquisa de artigos nas bases de dados PubMed, Google Scholar, Scielo e LILACS, utilizando-se os descritores: dyspnea, dispneia, dispnea, breathlessness, conceptualization, psychophysical. Considerou-se como critério de inclusão: trabalhos que apresentassem conceitos de dispneia e/ou falta de ar, com base em estudos descritivos/não experimentais ou com abordagem qualitativa. Resultados: foram identificados um total de 20828 títulos de artigos. Respeitando-se os critérios de inclusão, exclusão e as duplicidades, ao final da seleção, foram considerados 47 artigos. Conclusão: há consenso entre a maioria dos autores quanto ao fato da dispneia ser um sintoma, uma percepção, uma experiência subjetiva ou uma sensação, impactando na saúde e qualidade de vida dos indivíduos com diferentes estados de saúde.

Palavras-chave

Dispneia; Falta de Ar; Cansaço; Revisão Integrativa.

Referências

1. Cavallazzi TGL, Cavallazzi RS, Cavalcante TMC, Bettencourt ARC, Diccini S. Avaliação do uso da Escala Modificada de Borg na crise asmática. Acta Paul Enferm. 2005;18(1):39-45. http://dx.doi.org/10.1590/S0103-21002005000100006.

2. O’Donnell DE, James MD, Milne KM, Neder JA. The pathophysiology of dyspnea and exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med. 2019 Jun;40(2):343-66. http://dx.doi.org/10.1016/j. ccm.2019.02.007. PMid:31078214.

3. Hutchinson A, Barclay-Klingle N, Galvin K, Johnson MJ. Living with breathlessness: a systematic literature review and qualitative synthesis. Eur Respir J. 2018 Fev 21;51(2):1701477. http://dx.doi.org/10.1183/13993003.01477-2017. PMid:29467199.

4. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999 Jan;159(1):321-40. http://dx.doi. org/10.1164/ajrccm.159.1.ats898. PMid:9872857.

5. Lima PB, Santoro IL, Caetano LB, Cabral LB, Fernandes ALG. Performance of a word labeled visual analog scale in determining the degree of dyspnea during exercise-induced bronchoconstriction in children and adolescents with asthma. J Bras Pneumol. 2010;36(5):532-8. http://dx.doi. org/10.1590/S1806-37132010000500003. PMid:21085817.

6. Borg GA, Noble B. Perceived exertion. In Wilmore J, editor. Exercise and sport science reviews. New York: Academic Press; 1974, 131–53.

7. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81. http://dx.doi. org/10.1249/00005768-198205000-00012. PMid:7154893.

8. Martins R, Assumpção MS, Schivinski CIS. Percepção de esforço e dispneia em pediatria: revisão das escalas de avaliação. Medicina. 2014; 47(1):25-3. http://dx.doi. org/10.11606/issn.2176-7262.v47i1p25-35.

9. Martins R, Gonçalves RM, Minsky RC, Mayer AF, Schivinski CIS. Escala de percepção de esforço para criança (EPEC): validação para o português em um teste submáximo. Rev Bras Educ Fís Esporte. 2020;34(3):513-22. http://dx.doi. org/10.11606/1807-5509202000030513.

10. Pieper L, Zernikow B, Drake R, Frosch M, Printz M, Wager J. Dyspnea in children with life-threatening and life-limiting complex chronic conditions. J Palliat Med. 2018 Abr;21(4):552-64. http://dx.doi.org/10.1089/jpm.2017.0240. PMid:29313744.

11. Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm. 2008;17(4):758-64. http://dx.doi.org/10.1590/S0104- 07072008000400018.

12. Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010;8(1):102-6. http://dx.doi. org/10.1590/s1679-45082010rw1134. PMid:26761761.

13. Victorson DE, Anton S, Hamilton A, Yount S, Cella D. A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease. Value Health. 2009 Set;12(6):1018-25. http://dx.doi. org/10.1111/j.1524-4733.2009.00547.x. PMid:19402847.

14. Serrano J, Jesús-Berríos Y, Santos RA, Dexter D, Nazario CM, Montalvo F. Adaptation of the medical research council dyspnea scale and the oxygen cost diagram for its use in Puerto Rico. P R Health Sci J. 2007 Jun;26(2):135-40. PMid:17722426.

15. Faull OK, Hayen A, Pattinson KTS. Breathlessness and the body: neuroimaging clues for the inferential leap. Cortex. 2017 Out;95:211-21. http://dx.doi.org/10.1016/j. cortex.2017.07.019. PMid:28915367.

16. Miura CTP, Gallani MCBJ, Domingues GBL, Rodrigues RCM, Stoller JK. cultural adaptation and reliability analysis of the modified dyspnea index for the Brazilian culture. Rev Lat Am Enfermagem. 2010;18(5):1020-30. http://dx.doi. org/10.1590/S0104-11692010000500025 PMid:21120424.

17. Nishimura K, Oga T, Nakayasu K, Ogasawara M, Hasegawa Y, Mitsuma S. How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population. BMJ Open. 2019 Jul 24;9(7):e025132. http://dx.doi. org/10.1136/bmjopen-2018-025132. PMid:31345963.

18. Rocker G, Young J, Donahue M, Farquhar M, Simpson C. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ. 2012 Jun 12;184(9):E497-504. http://dx.doi.org/10.1503/cmaj.111758. PMid:22529167.

19. Wainwright M. Sensing the airs: the cultural context for breathing and breathlessness in Uruguay. Med Anthropol. 2017 Maio-Jun;36(4):332-47. http://dx.doi.org/10.1080/014 59740.2017.1287180. PMid:28281829.

20. Muroi Y, Undem BJ. Targeting peripheral afferent nerve terminals for cough and dyspnea. Curr Opin Pharmacol. 2011 Jun;11(3):254-64. http://dx.doi.org/10.1016/j. coph.2011.05.006. PMid:21705272.

21. Fisher JT. The TRPV1 ion channel: implications for respiratory sensation and dyspnea. Respir Physiol Neurobiol. 2009 Maio 30;167(1):45-52. http://dx.doi. org/10.1016/j.resp.2009.01.009. PMid:19450765.

22. Abernethy AP, Wheeler JL. Total dyspnoea. Curr Opin Support Palliat Care. 2008 Jun;2(2):110-3. http://dx.doi. org/10.1097/SPC.0b013e328300cad0. PMid:18685406.

23. Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res. 2012 Set 25;13(1):85. http://dx.doi. org/10.1186/1465-9921-13-85. PMid:23006638.

24. O’Donnell DE. Breathlessness in patients with chronic airflow limitation: mechanisms and management. Chest. 1994 Set;106(3):904-12. http://dx.doi.org/10.1378/ chest.106.3.904. PMid:8082376.

25. Burdon JG, Pain MC, Rubinfeld AR, Nana A. Chronic lung diseases and the perception of breathlessness: a clinical perspective. Eur Respir J. 1994 Jul;7(7):1342-9. http://dx.doi. org/10.1183/09031936.94.07071342. PMid:7925915.

26. Mahler DA, Rosiello RA, Harver A, Lentine T, McGovern JF, Daubenspeck JA. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis. 1987 Jun;135(6):1229-33. http://dx.doi.org/10.1164/ arrd.1987.135.6.1229. PMid:3592398.

27. McGrath PJ, Pianosi PT, Unruh AM, Buckley CP. Dalhousie dyspnea scales: construct and content validity of pictorial scales for measuring dyspnea. BMC Pediatr. 2005;5:33. http://dx.doi.org/10.1186/1471-2431-5-33. PMid:16131402.

28. Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés M. Determinants of dyspnea in patients with different grades of stable asthma. J Asthma. 2003 Jun;40(4):375-82. http://dx.doi.org/10.1081/JAS-120018637. PMid:12870833.

29. Conno F, Spoldi E, Caraceni A, Ventafridda V. Does pharmacological treatment affect the sensation of breathlessness in termina l cancer pa t ients? Palliat Med. 1991;5(3):237-43. http://dx.doi. org/10.1177/026921639100500309.

30. Banzett RB, O’Donnell CR, Guilfoyle TE, Parshall MB, Schwartzstein RM, Meek PM, et al. Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research. Eur Respir J. 2015 Jun;45(6):1681-91. http://dx.doi. org/10.1183/09031936.00038914. PMid:25792641.

31. Wasserman K, Casaburi R. Dyspnea: physiological and pathophysiological mechanisms. Annu Rev Med. 1988;39(1):503-15. http://dx.doi.org/10.1146/annurev. me.39.020188.002443. PMid:3285788.

32. Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010 Jun 30;5(3):202- 10. http://dx.doi.org/10.1186/2049-6958-5-3-202. PMid:22958431.

33. Tobin MJ. Dyspnea. Pathophysiologic basis, clinical presentation, and management. Arch Intern Med. 1990 Ago;150(8):1604-13. http://dx.doi.org/10.1001/ archinte.1990.00040031604007. PMid:2200379.

34. Williams CM. Dyspnea. Cancer J. 2006 Set-Out;12(5):365-73. http://dx.doi.org/10.1097/00130404-200609000-00006. PMid:17034673.

35. Parshall MB, Welsh JD, Brockopp DY, Heiser RM, Schooler MP, Cassidy KB. Dyspnea duration, distress, and intensity in emergency department visits for heart failure. Heart Lung. 2001 Jan-Fev;30(1):47-56. http://dx.doi.org/10.1067/ mhl.2001.112492. PMid:11174367.

36. Sahebjami H. Dyspnea in obese healthy men. Chest. 1998 Nov;114(5):1373-7. http://dx.doi.org/10.1378/ chest.114.5.1373. PMid:9824017.

37. Vijayan S, Singh B, Ghosh S, Stell R, Mastaglia FL. Dyspnea in Parkinson’s disease: an approach to diagnosis and management. Expert Rev Neurother. 2020 Jun;20(6):619- 26. http://dx.doi.org/10.1080/14737175.2020.1763795. PMid:32419523.

38. Martinez JA, Straccia L, Sobrani E, Silva GA, Vianna EO, Filho JT. Dyspnea scales in the assessment of illiterate patients with chronic obstructive pulmonary disease. Am J Med Sci. 2000 Out;320(4):240-3. http://dx.doi.org/10.1016/S0002- 9629(15)40833-X. PMid:11061348.

39. Collard HR, Pantilat SZ. Dyspnea in interstitial lung disease. Curr Opin Support Palliat Care. 2008;2(2):100-4. http:// dx.doi.org/10.1097/SPC.0b013e3282ff6336 PMid:18685404.

40. Gondos T, Szabó V, Sárkány Á, Sárkány A, Halász G. Estimation of the severity of breathlessness in the emergency department: a dyspnea score. BMC Emerg Med. 2017 Abr 26;17(1):13. http://dx.doi.org/10.1186/s12873-017- 0125-6. PMid:28441939.

41. Stendardi L, Binazzi B, Scano G. Exercise dyspnea in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(4):429- 39. PMid:18268917.

42. Malik FA, Gysels M, Higginson IJ. Living with breathlessness: a survey of caregivers of breathless patients with lung cancer or heart failure. Palliat Med. 2013 Jul;27(7):647-56. http:// dx.doi.org/10.1177/0269216313488812. PMid:23703238.

43. Ambrosino N, Scano G. Measurement and treatment of dyspnoea. Respir Med. 2001 Jul;95(7):539-47. http://dx.doi. org/10.1053/rmed.2001.1111. PMid:11453309.

44. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006 Maio;3(3):234-8. http://dx.doi.org/10.1513/ pats.200509-103SF. PMid:16636091.

45. Williams MT, Johnston KN. Multidimensional measurement of breathlessness: recent advances. Curr Opin Support Palliat Care. 2019 Set;13(3):184-92. http://dx.doi.org/10.1097/ SPC.0000000000000436. PMid:31145135.

46. Skevington SM, Pilaar M, Routh D, Macleod RD. On the language of breathlessness. Psychol Health. 1997;12(5):677- 89. http://dx.doi.org/10.1080/08870449708407414.

47. Martins R, Assumpção MS, Schivinski CIS. Percepção de esforço e dispneia em pediatria: revisão das escalas de avaliação. Medicina. 2014;47(1):25-3. http://dx.doi. org/10.11606/issn.2176-7262.v47i1p25-35.

48. Parente AA, March MF, Evangelista LA, Cunha AL. Perception of dyspnea in childhood asthma crisis by the patients and those in charge of them. J Pediatr. 2011;87(6):541-6. http:// dx.doi.org/10.2223/JPED.2144. PMid:22170258.

49. Hareendran A, Leidy NK, Monz BU, Winnette R, Becker K, Mahler DA. Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:345-55. http://dx.doi.org/10.2147/COPD.S29571. PMid:22745534.

50. Laveneziana P. Qualitative aspects of exertional dyspnea in patients with restrictive lung disease. Multidiscip Respir Med. 2010 Jun 30;5(3):211-5. http://dx.doi.org/10.1186/2049- 6958-5-3-211. PMid:22958444.

51. Voogd JN, Sanderman R, Postema K, van Sonderen E, Wempe JB. Relationship between anxiety and dyspnea on exertion in patients with chronic obstructive pulmonary disease. Anxiety Stress Coping. 2011 Jul;24(4):439-49. http://dx.doi. org/10.1080/10615806.2010.520081. PMid:20936544.

52. Lewthwaite H, Koch EM, Tracey L, Jensen D. Standardized measurement of breathlessness during exercise. Curr Opin Support Palliat Care. 2019 Set;13(3):152-60. http://dx.doi. org/10.1097/SPC.0000000000000443. PMid:31268873.

53. Killian KJ. The objective measurement of breathlessness. Chest. 1985;88(2 Suppl):84S-90. http://dx.doi.org/10.1378/ chest.88.2_Supplement.84S. PMid:4017699.

54. Bausewein C, Booth S, Gysels M, Kühnbach R, Haberland B, Higginson IJ. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med. 2010 Set;13(9):1109-18. http://dx.doi.org/10.1089/ jpm.2010.0068. PMid:20836635.

55. O’Donnell DE, Milne KM, Vincent SG, Neder JA. Unraveling the causes of unexplained dyspnea: the value of exercise testing. Clin Chest Med. 2019 Jun;40(2):471-99. http://dx.doi. org/10.1016/j.ccm.2019.02.014. PMid:31078223.

56. Burki NK. Dyspnea. Lung. 1987;165(5):269-77. http://dx.doi. org/10.1007/BF02714443. PMid:3116351.

57. Horton R, Rocker G, Currow D. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease? Curr Opin Support Palliat Care. 2010 Jun;4(2):92-6. http://dx.doi.org/10.1097/ SPC.0b013e3283392788. PMid:20443250.


Submetido em:
31/08/2021

Aceito em:
23/03/2022

62a74178a95395512b1fca26 assobrafir Articles
Links & Downloads

ASSOBRAFIR Ciência

Share this page
Page Sections